Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peter Grell

3PUBLICATIONS

48CO-AUTHORS

Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 25, 2026

Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Mar 05, 2025

A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.

Sumanta K Pal, Alice Bernard-Tessier, Peter Grell

|Mar 29, 2023

FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer.

Peter Grell, Simona Borilova, Pavel Fabian

Pageof 1

Frequent Collaborators

1 joint publications

Simona Borilova

1 joint publications

Iveta Selingerova

1 joint publications

Petr Muller

1 joint publications

Sumanta K Pal

1 joint publications

Alice Bernard-Tessier

1 joint publications

Xin Gao

1 joint publications

Ritesh R Kotecha

1 joint publications

Joel Picus

1 joint publications

Filippo de Braud

1 joint publications

Shunji Takahashi

Frequent Collaborators

1 joint publications

Simona Borilova

1 joint publications

Iveta Selingerova

1 joint publications

Petr Muller

1 joint publications

Sumanta K Pal